Carl Perez
Corporate Officer/Principal at The Vancouver Prostate Centre
Profile
Carl F.
Perez is a professional with experience in project management, preclinical programs, and product development.
He is currently working as a Project Manager at The Vancouver Prostate Centre since 2015.
Previously, he worked as a Director-Preclinical Programs at Chromos Molecular Systems, Inc. from 1997 to 2007 and as a Chief Technical Officer at LeanLife Health, Inc. from 2018 to 2020.
He also held the position of Vice President-Product Development at Metaara Medical Technologies.
Dr. Perez completed his undergraduate, graduate, and doctorate degrees from the University of California, Berkeley in 1980, 1981, and 1984 respectively.
Carl Perez active positions
| Companies | Position | Start |
|---|---|---|
The Vancouver Prostate Centre
 The Vancouver Prostate Centre Miscellaneous Commercial ServicesCommercial Services The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 2015-01-31 |
Former positions of Carl Perez
| Companies | Position | End |
|---|---|---|
| LEANLIFE HEALTH INC. | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Chromos Molecular Systems, Inc.
 Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Corporate Officer/Principal | 2007-03-31 |
| Metaara Medical Technologies | Corporate Officer/Principal | - |
Training of Carl Perez
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEANLIFE HEALTH INC. | Retail Trade |
| Private companies | 3 |
|---|---|
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
The Vancouver Prostate Centre
The Vancouver Prostate Centre Miscellaneous Commercial ServicesCommercial Services The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada. | Commercial Services |
| Metaara Medical Technologies |
- Stock Market
- Insiders
- Carl Perez
